首页> 外国专利> APPLICATION OF PEPTIDYLARGININE DEIMINASE 1 IN PREPARATION OF REAGENT FOR CLINICAL DIAGNOSIS OF TUMORS

APPLICATION OF PEPTIDYLARGININE DEIMINASE 1 IN PREPARATION OF REAGENT FOR CLINICAL DIAGNOSIS OF TUMORS

机译:肽精氨酸脱氨酶1在制备肿瘤临床诊断试剂中的应用

摘要

An application of peptidylarginine deiminase 1 in preparation of a reagent or detection object for clinical diagnosis of tumors, wherein the tumors comprise uterine cancers, liver cancers, gastric cancers, esophageal cancers, ovarian cancers and lung cancers. In the specific application, an antibody against peptidylarginine deiminase 1 is prepared by a conventional method, and a qualitative or quantitative method and a matching kit for detecting peptidylarginine deiminase 1 are established. A blood diagnosis reagent for diagnosing tumors comprises a peptidylarginine deiminase 1 antibody, an HRP-IgG antibody and conventional reagents in the blood diagnosis reagent, wherein the conventional reagents in the blood diagnosis reagent comprise a carbonate buffer solution, a PBST lotion, a blocking solution, a developing solution and a stop solution. Experiments prove that PAD1 can be applied as a tumor blood marker, and PAD1 has feasibility as the tumor marker.
机译:肽基精氨酸脱亚氨酶1在制备用于临床诊断肿瘤的试剂或检测对象中的应用,其中所述肿瘤包括子宫癌,肝癌,胃癌,食道癌,卵巢癌和肺癌。在具体的应用中,通过常规方法制备了针对肽基精氨酸脱亚氨酶1的抗体,并建立了定性或定量方法以及用于检测肽基精氨酸脱亚氨酶1的配套试剂盒。一种用于诊断肿瘤的血液诊断试剂,其包括肽酰精氨酸脱亚氨酶1抗体,HRP-IgG抗体和血液诊断试剂中的常规试剂,其中,血液诊断试剂中的常规试剂包括碳酸盐缓冲液,PBST洗剂,封闭液。 ,开发解决方案和停止解决方案。实验证明,PAD1可以作为肿瘤的血液标志物,PAD1具有作为肿瘤标志物的可行性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号